# GlaxoSmithKline Pharmaceuticals Ltd (GLAXO)
> Exchange: NSE | Sector: Pharma | ISIN: INE159A01016

## Price
Current Price: ₹2,868.1
Day Change: -0.63%
52W High: ₹3120.7
52W Low: ₹2088.1
Market Cap: ₹47,916 Cr

## About
GlaxoSmithKline Pharmaceuticals Ltd is a Pharma company listed on NSE.
Sector: Pharma

## Returns
1Y Return: 21.06%

## Valuation
P/E: 45.5
P/B: 21.1
EPS: ₹62.15
Book Value: ₹134
Dividend Yield: 2.0200000000000005%

## Profitability
ROE: 45.6%

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-09-10T06:01:00.000Z
Price History Updated: 2026-09-10T18:56:31.413Z
Latest Price History Date: 2026-09-10
Technicals Updated: 2026-09-10T18:56:31.413Z
Quant Updated: 2026-09-10T18:56:31.413Z
Sentiment Updated: 2026-09-10T18:56:31.413Z
Financials Status: current
Financials Updated: 2026-09-11T13:27:27.307Z
Financials Last Attempt: 2026-09-11T13:27:27.307Z
Financials Provider Tried: screener.in+yahoo
Latest P&L Period: FY26
Latest Balance Sheet Period: FY26
Latest Cash Flow Period: FY26

## P&L (TTM)
Revenue: ₹3955 Cr
Operating Profit: ₹1354 Cr (OPM 34%)
Net Profit: ₹1068 Cr
Tax: ₹381 Cr

## Annual P&L History
TTM: Rev ₹3955Cr | PAT ₹1068Cr | OPM 34%
FY26: Rev ₹3822Cr | PAT ₹1036Cr | OPM 34%
FY25: Rev ₹3749Cr | PAT ₹928Cr | OPM 31%

## Balance Sheet (FY26)
Total Assets: ₹4324 Cr
Total Liabilities: ₹4324 Cr
Borrowings: ₹33 Cr
Cash: —

## Shareholding
Promoters: 75%
FIIs: 4.79%
DIIs: 7.81%
Public: 12.42%

---
Source: rupiya.io/stocks/glaxo
Disclaimer: For research and education only. Not investment advice.